Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Seismic Therapeutic | 2024 | Series B | $25.0M | Watertown |
| Noetik | 2024 | Grant | $1.0M | South San Francisco |
| EGenesis | 2024 | Series D | $191.0M | Cambridge |
| BeMe Health | 2024 | Seed | $12.5M | Miami |
| Allstacks | 2024 | Series A | $10.0M | Raleigh |
| Cardurion Pharmaceuticals | 2024 | Series B | $260.0M | Boston |
| Vico Therapeutics | 2024 | Series B | $12.3M | Leiden |
| Lore | 2024 | Series A | $80.0M | San Diego |
| Delphia Therapeutics | 2024 | Series A | $67.0M | Cambridge |
| Livara Health | 2024 | Series B | $15.0M | San Diego |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Seismic Therapeutic | Series B | $25.0M | Watertown, United States |
| 52 | Noetik | Grant | $1.0M | South San Francisco, United States |
| 53 | EGenesis | Series D | $191.0M | Cambridge, United States |
| 54 | BeMe Health | Seed | $12.5M | Miami, United States |
| 55 | Allstacks | Series A | $10.0M | Raleigh, United States |
| 56 | Cardurion Pharmaceuticals | Series B | $260.0M | Boston, United States |
| 57 | Vico Therapeutics | Series B | $12.3M | Leiden, The Netherlands |
| 58 | Lore | Series A | $80.0M | San Diego, United States |
| 59 | Delphia Therapeutics | Series A | $67.0M | Cambridge, United States |
| 60 | Livara Health | Series B | $15.0M | San Diego, United States |
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Be Me Health is a mobile platform that focuses on the mental health and emotional well-being of teens.
Allstacks develops a software engineering intelligence platform to predict forecasting and risk management.
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Lore is a AI company build and encouraging, and judgment-free community where individuals may meet others who share their interests.
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
Livara Health is a provider of non-operative, personalized treatment for musculoskeletal conditions.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
FloQast is a financial close management software designed to streamline the month-end close process for accounting teams.
Tausight’s mission is to solve one of the most challenging responsibilities of healthcare CIOs, CISOs, and their IT organizations.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Vita Health delivers quality mental health care to adolescents and transitional age youth.
Over millions and millions of years, a collection of reward systems
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
CubicPV is a solar manufacturing company that produces wafers and tandem modules.
Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
Kallyope uses the science of gut-brain biology to create medicines that transform human health.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Polaris Partners has invested in 131 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Polaris Partners's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 33 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post Ipo Equity round. Polaris Partners's total known invested capital is $5.6B.
Polaris Partners's average investment size is $53.2M across its portfolio of 131 companies.
Recent Polaris Partners portfolio additions include Seismic Therapeutic, Noetik, EGenesis, BeMe Health, Allstacks. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors